# Prospective Validation of 3D Dose Metrics as Selection Criteria for Adaptive Radiotherapy in Breast Cancer Patients

> **NCT03385031** · — · COMPLETED · sponsor: **Maastricht Radiation Oncology** · enrollment: 46 (actual)

## Conditions studied

- Breast Cancer

## Interventions

- **OTHER:** CBCT imaging

## Key facts

- **NCT ID:** NCT03385031
- **Lead sponsor:** Maastricht Radiation Oncology
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2018-01-01
- **Primary completion:** 2018-08-20
- **Final completion:** 2018-08-20
- **Target enrollment:** 46 (ACTUAL)
- **Last updated:** 2019-03-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03385031

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03385031, "Prospective Validation of 3D Dose Metrics as Selection Criteria for Adaptive Radiotherapy in Breast Cancer Patients". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT03385031. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*